ADVANCEMENTS IN TARGETED CANCER THERAPIES: FROM MONOCLONAL ANTIBODIES TO IMMUNOTHERAPY. IJFANS. 2022;11(12):17887-17896. Accessed July 17, 2026. https://www.ijfans.org/index.php/Journal/article/view/14322